Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 10 (2) , 111-116
- https://doi.org/10.1016/s0167-8140(87)80053-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799International Journal of Radiation Oncology*Biology*Physics, 1986
- Some factors of importance in the radiation treatment of malignant melanomaRadiotherapy and Oncology, 1986
- The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometryCytometry, 1985
- A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanomaInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrationsInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Response rate of malignant melanoma to large fraction irradiationThe British Journal of Radiology, 1982
- The radiosensitivity of malignant melanomas part II: Clinical studiesInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Radiation treatment of malignant melanomaInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Radiation therapy of malignant melanoma.Experience with high individual treatment dosesCancer, 1976